These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36493860)

  • 1. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
    Golub V; Ramakrishnan S; Reddy DS
    Exp Neurol; 2023 Feb; 360():114294. PubMed ID: 36493860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam.
    Chuang SH; Reddy DS
    J Pharmacol Exp Ther; 2020 Mar; 372(3):285-298. PubMed ID: 31843812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures.
    Reddy DS; Mbilinyi RH; Ramakrishnan S
    Exp Neurol; 2023 Jan; 359():114240. PubMed ID: 36216124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.
    Talwar A; Estes E; Aparasu R; Reddy DS
    Exp Neurol; 2023 Jan; 359():114238. PubMed ID: 36206805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.
    Patra PH; Barker-Haliski M; White HS; Whalley BJ; Glyn S; Sandhu H; Jones N; Bazelot M; Williams CM; McNeish AJ
    Epilepsia; 2019 Feb; 60(2):303-314. PubMed ID: 30588604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia.
    Neubauer D; Perković Benedik M; Osredkar D
    Epilepsy Behav; 2018 Apr; 81():79-85. PubMed ID: 29526578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
    Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
    Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
    Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
    Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiseizure effects of the cannabinoids in the amygdala-kindling model.
    Fallah MS; Dlugosz L; Scott BW; Thompson MD; Burnham WM
    Epilepsia; 2021 Sep; 62(9):2274-2282. PubMed ID: 34251027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
    Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
    Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam.
    Rana RR; Rajasekaran K; Knappertz V; Gray RA
    Exp Neurol; 2023 Feb; 360():114286. PubMed ID: 36442674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosteroids and Seizure Activity.
    Miziak B; Chrościńska-Krawczyk M; Czuczwar SJ
    Front Endocrinol (Lausanne); 2020; 11():541802. PubMed ID: 33117274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.